Interstitial Lung Disease

Update on the Evaluation and Management of Interstitial Lung Abnormalities
New guidelines outline the screening and follow-up procedures for ILAs as well as define who is at higher risk for progressing to ILD.

Current Standards in Donor Lung Procurement and Preservation
Review expert consensus guidelines for improving standardization in key areas of lung acquisition and procurement.

CHEST Grant Recipient Reflects on Completed Project in Streamlining ILD Diagnoses
With her project complete, Kavitha Selvan, MD, shares how her ILD grant has impacted patient care, affected providers, and supported her growth as a clinician.

Optimizing Lung Transplant Care: The Expanding Role of APPs
In the evolving landscape of transplant medicine, APPs are utilizing their clinical experience, consistency, and adaptability to help them manage the complexities associated with transplant across care settings.

The Respiratory Toll of Traffic Pollution in Obstructive Lung Disease, ILD
Air pollution reduces lung function and worsens cases of COPD and ILD. Pulmonologists should assess patient exposure and advise on mitigation strategies.

GOLDen Handcuffs: Beyond Spirometry in COPD
When it comes to diagnosing COPD, clinicians must look beyond spirometry and physiology to see a patient fully.

Study Identifies Key Environmental Exposures Associated With Risk of Interstitial Lung Disease
Bradford C. Bemiss, MD, MSc, said the findings underscore the importance of asking patients about potential workplace inhalation exposures.

Nerandomilast Opens the Door for Potential Monotherapy, Add-On Therapy for Pulmonary Fibrosis
Positive results from the FIBRONEER trials of nerandomilast in IPF and PPF have sent the phosphodiesterase 4B inhibitor to the FDA for marketing approval.